Because our current knowledge on the mechanisms of ETAS®50 and brain function are limited, transgenic mice overexpressing APP were used in our studies, as previously described by Simón et al. [20] while elucidating the mechanisms of Alzheimer disease [21]. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.